For inquiries or customized services, please reach us at pr@pharmaceutical-era.com
BD a leading global medical technology company, announced positive nine-month results from the iliac cohort of the AGILITY Investigational Device Exemption trial evaluating the Revello™ Vascular...
Nordic Pharma, Inc., a subsidiary of SEVER Life Sciences B.V., will be held at the annual meeting of the American Academy of Ophthalmology from 9 to 12. October in New Orleans, Louisiana, introduce...
Arkayli BioPharma Inc. a biopharmaceutical company dedicated to developing innovative therapies for rare dermatologic conditions, announced that the U.S. Food and Drug Administration (FDA) has...
Carterra®, a leading provider of high-throughput surface plasmon resonance (HT-SPR™) platforms for antibody and small molecule drug discovery, announced a research collaboration with AstraZeneca to...
MedaSystems, a SaaS platform for managing Expanded Access, Post-Trial Access and Investigator-Initiated Study programs, announced the release of MedaSystems Version 3.3, one of the company’s most...
Dr. Oregonin Inc. announced that it has completed U.S. Food and Drug Administration (FDA) registration for OLTIS DENTAL-X, paving the way for its official commercial entry into the North American...
A larger rebate does not guarantee lower pharmacy spending, warns Paul Pruitt, Chief Growth Officer and Co-Founder of SHARx, a procurement management solution for high-cost prescription drugs....
Aptar Pharma, a global leader in drug delivery, dosing, protection technologies and services, announced the launch of Premia™ Precision, a new quality standard for elastomer components, designed to...
Hovione, a globally integrated pharmaceutical contract development and manufacturing organization (CDMO), announced it will commission the world's first ConsiGma® CDC Flex – a next generation...
CaseBioscience® announced its participation in a multidisciplinary team led by Likarda that has been awarded up to $7.3 million by the Advanced Research Projects Agency for Health (ARPA-H) through its...
Ensera, a global CDMO specializing in commercialization support for injectable drug programs, has launched the Ensera Alliance Network, bringing together leading device platform and fill-finish...
Niagen Bioscience, Inc. the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced the launch of “Don't Get Old. Age Better.®,” a new...
